J M Nightingale1, E R Walker, W R Burnham
1St Mark's Hospital, London, UK.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Octreotide effectively reduced intestinal output in short bowel syndrome patients with secretory issues. Long-term use decreased fluid replacement needs in some patients.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: